WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

  • WJAHR: AUGUST ISSUE PUBLISHED

    AUGUST 2026 Issue has been successfully launched on AUGUST 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR August 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

PREDICTIVE VALUE OF THE SYSTEMIC IMMUNE-INFLAMMATION INDEX AND RESIDUAL SYNTAX SCORE FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION AT AL-KINDY TEACHING HOSPITAL, BAGHDAD

*Dr. Hasan Ahmed Fadaam, Dr. Khulood Abed Reman

ABSTRACT

Background: Major adverse cardiovascular events (MACE) remain an important cause of morbidity and mortality following percutaneous coronary intervention (PCI). The Systemic Immune-Inflammation Index (SII) and Residual SYNTAX Score (rSS) have emerged as promising prognostic markers in patients undergoing PCI. Aims: To evaluate the predictive value of the Systemic Immune-Inflammation Index and Residual SYNTAX Score for major adverse cardiovascular events following percutaneous coronary intervention at Al-Kindy Teaching Hospital, Baghdad. Patients and Methods: This retrospective cohort study included 113 patients who underwent PCI at Al-Kindy Teaching Hospital between February 2023 and May 2026. Demographic, clinical, laboratory, angiographic, and procedural data were collected. The Systemic Immune-Inflammation Index was calculated using platelet, neutrophil, and lymphocyte counts, while the Residual SYNTAX Score was determined after PCI. Major adverse cardiovascular events, including cardiac death, nonfatal myocardial infarction, stroke, repeat revascularization, and hospitalization for heart failure, were recorded during follow-up. Receiver operating characteristic curve analysis and multivariate logistic regression analysis were performed to evaluate the predictive value of the studied parameters. Results: The mean age of the study population was 59.3 ± 10.8 years, and 71.7% of patients were male. Major adverse cardiovascular events occurred in 24 patients (21.2%) during follow-up. Patients who developed MACE had significantly higher mean SII values than those without adverse outcomes (1124.3 ± 402.1 versus 729.8 ± 285.6, P < 0.001). Similarly, the residual SYNTAX score was significantly higher among patients with MACE (9.1 ± 4.8 versus 4.9 ± 3.2, P < 0.001). Receiver operating characteristic analysis demonstrated that SII predicted MACE with an area under the curve (AUC) of 0.78, whereas residual SYNTAX score demonstrated an AUC of 0.82. The combined model of SII and residual SYNTAX score yielded the highest predictive accuracy with an AUC of 0.87. Multivariate logistic regression analysis identified elevated SII (OR = 2.84, 95% CI: 1.45–5.56, P = 0.002) and higher residual SYNTAX score (OR = 3.27, 95% CI: 1.72–6.23, P < 0.001) as independent predictors of major adverse cardiovascular events. Conclusions: The Systemic Immune-Inflammation Index and Residual SYNTAX Score are significant independent predictors of major adverse cardiovascular events following percutaneous coronary intervention. The combined use of these parameters provides superior prognostic accuracy compared with either marker alone and may represent a valuable strategy for comprehensive cardiovascular risk stratification in patients undergoing PCI.

[Full Text Article] [Download Certificate]